Tegumentary Leishmaniasis
Mostrando 1-12 de 90 artigos, teses e dissertações.
-
1. Epidemiological aspects of Leishmaniasis in the Pantanal region of Mato Grosso
Resumo As leishmanioses são doenças causadas por protozoários do gênero Leishmania disseminadas por algumas espécies de flebotomíneos e participação de uma variedade de reservatórios. O objetivo do presente estudo foi avaliar a situação epidemiológica das leishmanioses nos municípios abrangentes do Pantanal de Mato Grosso. Os dados humanos foram
Rev. Bras. Parasitol. Vet.. Publicado em: 30/09/2019
-
2. Leishmanioses: sua configuração histórica no Brasil com ênfase na doença visceral nos anos 1930 a 1960
Resumo Casos pioneiros de leishmaniose cutânea e mucocutânea nas Américas foram descritos em São Paulo, em 1909; somente em 1934, um patologista do Serviço de Febre Amarela encontrou a leishmaniose visceral no Brasil. Processos históricos concernentes a essas formas ganharam mais vigor institucional nos anos 1930. Se a Comissão para o Estudo da Leishm
Bol. Mus. Para. Emílio Goeldi. Ciênc. hum.. Publicado em: 26/08/2019
-
3. Diagnostic accuracy of Enzyme-Linked Immunosorbent Assays to detect anti-Leishmania antibodies in patients with American Tegumentary Leishmaniasis: a systematic review
ABSTRACT American Tegumentary leishmaniasis (ATL) is an infectious disease caused by several species of Leishmania . Even though the direct detection of parasites has low sensitivity, it is still the gold standard for the laboratory diagnosis of ATL. Recent studies have shown promising results of Enzyme-Linked Immunosorbent Assays ( ELISAs) using recombinant
Rev. Inst. Med. trop. S. Paulo. Publicado em: 19/08/2019
-
4. Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake
BACKGROUND In addition to the limited therapeutic arsenal and the side effects of antileishmanial agents, drug resistance hinders disease control. In Brazil, Leishmania braziliensis causes atypical (AT) tegumentary leishmaniasis lesions, frequently refractory to treatment. OBJECTIVES The main goal of this study was to characterise antimony (Sb)-resistant
Mem. Inst. Oswaldo Cruz. Publicado em: 15/08/2019
-
5. American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure
Abstract: Pentavalent antimonials are the first-line drug treatment for American tegumentary leishmaniasis. We report on a patient with chronic renal failure on hemodialysis who presented with cutaneous lesions of leishmaniasis for four months. The patient was treated with intravenous meglumine under strict nephrological surveillance, but cardiotoxicity, acu
An. Bras. Dermatol.. Publicado em: 29/07/2019
-
6. Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil
Abstract INTRODUCTION: American tegumentary leishmaniasis (ATL) and leprosy share common areas of prevalence, but reports of coinfection are scarce. METHODS: We report a series of 9 ATL-leprosy cases and discuss the association. An integrative diagram to analyze the clinico-immunological features of coinfection with both diseases. RESULTS: Nine patients
Rev. Soc. Bras. Med. Trop.. Publicado em: 11/04/2019
-
7. American Tegumentary Leishmaniasis in the Brazilian Amazon from 2010 to 2014
ABSTRACT American tegumentary leishmaniasis (ATL) is one of the most important but neglected infectious diseases, and can cause severe deformities. ATL incidence remains high in forest regions, such as in the Amazonas State, Brazil. However, differences within the State and over time have been observed, since infection patterns are not homogeneous, and these
Rev. Inst. Med. trop. S. Paulo. Publicado em: 08/04/2019
-
8. Tegumentary leishmaniasis diagnosis: what happened with MST (Montenegro Skin Test) in Brazil?
Rev. Inst. Med. trop. S. Paulo. Publicado em: 11/03/2019
-
9. TGF-β1 polymorphism in American tegumentary leishmaniasis in a Southern Brazilian population
Abstract INTRODUCTION: Genetic polymorphisms define the cytokine production leading to susceptibility or resistance to diseases. We studied the cytokine polymorphism in the development of tegumentary leishmaniasis (TL). METHODS: Genotyping of TNF-α, TGF-β1, IFN-γ, IL-6, and IL-10 were performed by polymerase chain reaction assay. RESULTS: G and C all
Rev. Soc. Bras. Med. Trop.. Publicado em: 21/02/2019
-
10. Temporal and spatial distribution of American tegumentary leishmaniasis in north Paraná: 2010-2015
Abstract INTRODUCTION: Describing the general aspects of American tegumentary leishmaniasis enables the identification of the epidemiological scenario of the disease and the development of preventive actions. METHODS: We analyzed the records of patients with American tegumentary leishmaniasis in north Paraná between 2010 and 2015. RESULTS: We identifi
Rev. Soc. Bras. Med. Trop.. Publicado em: 14/02/2019
-
11. Disseminated leishmaniasis: clinical, pathogenic, and therapeutic aspects
Abstract: Disseminated leishmaniasis is a severe and emerging form of American tegumentary leishmaniasis. Disseminated leishmaniasis is defined by the presence of more than 10 polymorphic cutaneous lesions, distributed over more than two noncontiguous parts of the body. Nasal mucosal involvement is observed in almost half of cases. Disseminated leishmaniasis
An. Bras. Dermatol.. Publicado em: 2019-02
-
12. Use of the polymerase chain reaction for the diagnosis of American tegumentary leishmaniasis
An. Bras. Dermatol.. Publicado em: 2019-02